Copyright Reports & Markets. All rights reserved.

Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cystic Fibrosis Transmembrane Conductance Regulator Modulator by Type
    • 1.3.1 Overview: Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value Market Share by Type in 2025
    • 1.3.3 Correctors
    • 1.3.4 Potentiators
    • 1.3.5 Amplifiers
  • 1.4 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market by Application
    • 1.4.1 Overview: Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Clinical
    • 1.4.3 Non-clinical
  • 1.5 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size & Forecast
  • 1.6 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast by Region
    • 1.6.1 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Region, (2021-2032)
    • 1.6.3 North America Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Prospect (2021-2032)
    • 1.6.6 South America Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Vertex Pharmaceuticals
    • 2.1.1 Vertex Pharmaceuticals Details
    • 2.1.2 Vertex Pharmaceuticals Major Business
    • 2.1.3 Vertex Pharmaceuticals Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product and Solutions
    • 2.1.4 Vertex Pharmaceuticals Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Vertex Pharmaceuticals Recent Developments and Future Plans
  • 2.2 ReCode Therapeutics
    • 2.2.1 ReCode Therapeutics Details
    • 2.2.2 ReCode Therapeutics Major Business
    • 2.2.3 ReCode Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product and Solutions
    • 2.2.4 ReCode Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 ReCode Therapeutics Recent Developments and Future Plans
  • 2.3 Arcturus Therapeutics
    • 2.3.1 Arcturus Therapeutics Details
    • 2.3.2 Arcturus Therapeutics Major Business
    • 2.3.3 Arcturus Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product and Solutions
    • 2.3.4 Arcturus Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Arcturus Therapeutics Recent Developments and Future Plans
  • 2.4 AbbVie
    • 2.4.1 AbbVie Details
    • 2.4.2 AbbVie Major Business
    • 2.4.3 AbbVie Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product and Solutions
    • 2.4.4 AbbVie Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 AbbVie Recent Developments and Future Plans
  • 2.5 Spirovant Sciences
    • 2.5.1 Spirovant Sciences Details
    • 2.5.2 Spirovant Sciences Major Business
    • 2.5.3 Spirovant Sciences Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product and Solutions
    • 2.5.4 Spirovant Sciences Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Spirovant Sciences Recent Developments and Future Plans
  • 2.6 4D Molecular Therapeutics
    • 2.6.1 4D Molecular Therapeutics Details
    • 2.6.2 4D Molecular Therapeutics Major Business
    • 2.6.3 4D Molecular Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Product and Solutions
    • 2.6.4 4D Molecular Therapeutics Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 4D Molecular Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Cystic Fibrosis Transmembrane Conductance Regulator Modulator by Company Revenue
    • 3.2.2 Top 3 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Players Market Share in 2025
    • 3.2.3 Top 6 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Players Market Share in 2025
  • 3.3 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market: Overall Company Footprint Analysis
    • 3.3.1 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market: Region Footprint
    • 3.3.2 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market: Company Product Type Footprint
    • 3.3.3 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value by Type (2021-2032)
  • 6.2 North America Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Application (2021-2032)
  • 6.3 North America Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Country
    • 6.3.1 North America Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value by Country (2021-2032)
    • 6.3.2 United States Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value by Type (2021-2032)
  • 7.2 Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value by Application (2021-2032)
  • 7.3 Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Country
    • 7.3.1 Europe Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)
    • 7.3.3 France Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Region
    • 8.3.1 Asia-Pacific Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value by Region (2021-2032)
    • 8.3.2 China Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)
    • 8.3.5 India Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value by Type (2021-2032)
  • 9.2 South America Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value by Application (2021-2032)
  • 9.3 South America Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Country
    • 9.3.1 South America Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size by Country
    • 10.3.1 Middle East & Africa Cystic Fibrosis Transmembrane Conductance Regulator Modulator Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Drivers
  • 11.2 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Market Restraints
  • 11.3 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Industry Chain
  • 12.2 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Upstream Analysis
  • 12.3 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Midstream Analysis
  • 12.4 Cystic Fibrosis Transmembrane Conductance Regulator Modulator Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cystic Fibrosis Transmembrane Conductance Regulator Modulator market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Cystic Fibrosis Transmembrane Conductance Regulator Modulator market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Cystic Fibrosis Transmembrane Conductance Regulator Modulator market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Cystic Fibrosis Transmembrane Conductance Regulator Modulator
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Cystic Fibrosis Transmembrane Conductance Regulator Modulator market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vertex Pharmaceuticals, ReCode Therapeutics, Arcturus Therapeutics, AbbVie, Spirovant Sciences, 4D Molecular Therapeutics, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Cystic Fibrosis Transmembrane Conductance Regulator Modulator market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Correctors
    Potentiators
    Amplifiers
    Market segment by Application
    Clinical
    Non-clinical
    Market segment by players, this report covers
    Vertex Pharmaceuticals
    ReCode Therapeutics
    Arcturus Therapeutics
    AbbVie
    Spirovant Sciences
    4D Molecular Therapeutics
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Cystic Fibrosis Transmembrane Conductance Regulator Modulator product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Cystic Fibrosis Transmembrane Conductance Regulator Modulator, with revenue, gross margin, and global market share of Cystic Fibrosis Transmembrane Conductance Regulator Modulator from 2021 to 2026.
    Chapter 3, the Cystic Fibrosis Transmembrane Conductance Regulator Modulator competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Cystic Fibrosis Transmembrane Conductance Regulator Modulator market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Cystic Fibrosis Transmembrane Conductance Regulator Modulator.
    Chapter 13, to describe Cystic Fibrosis Transmembrane Conductance Regulator Modulator research findings and conclusion.

    Buy now